Call for Abstract

3rd International Conference on Neuro-Oncology and Brain Tumor, will be organized around the theme “Innovative Techniques and Advancements in Neuro-Oncology”

Neuro Oncology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neuro Oncology 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The Central Nervous System is denounced to various Malevolent disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple scelosis and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.

Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

  • Track 1-1Central Nervous System
  • Track 1-2Neurological Disorders
  • Track 1-3  Repeat Expansion Diseases
  • Track 1-4Transverse Myelitis
  • Track 1-5 Progressive Multifocal Leukoencephalopathy
  • Track 1-6 Meningitis and Encephalitis
  • Track 1-7 Neurosarcoidosis
  • Track 1-8CNS lymphoma
  • Track 1-9Motor Neuron Disease
  • Track 1-10Neuro degenerative disorders and Injury
  • Track 1-11Pediatric neurooncology

Brain Tumor occurs when abnormal cells form within the brain. The symptoms of Brain stem tumors vary greatly and can include Ataxia, Cranial Nerve Palsyheadaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.

  • Track 2-1Benign brain tumors
  • Track 2-2Oligodendroglioma
  • Track 2-3 All Gliomas
  • Track 2-4Prion diseases
  • Track 2-5Medulloblastoma
  • Track 2-6Craniopharyngioma
  • Track 2-7Chordoma
  • Track 2-8Tumor Biomarkers
  • Track 2-9Imaging studies
  • Track 2-10Malignant primary brain tumors
  • Track 2-11Astrocytoma

Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.

  • Track 3-1Glioma
  • Track 3-2Glioblastoma Multiforme
  • Track 3-3Ependymoma
  • Track 3-4Pontine Glioma
  • Track 3-5Vestibular schwannoma
  • Track 3-6Unspecified glioma
  • Track 3-7Astrocytoma

Neurosurgery or neurological surgery is the medical specialty focused on the prevention, diagnosis, and rehabilitation of disorders which affect any part of the nervous system such as brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. They help in the diagnosis of intra cerebral hemorrhage.

  • Track 4-1Cyber knife Radiosurgery
  • Track 4-2Cerebrovascular Neurosurgery
  • Track 4-3Funtional Neurosurgery
  • Track 4-4Pediatric Neurosurgery
  • Track 4-5skull base surgery

Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.

  • Track 5-1Metastases neoplastic
  • Track 5-2Meningitis
  • Track 5-3Metastases base of skull
  • Track 5-4Lung cancer and metastatic brain tumors
  • Track 5-5Kidney cancer and metastatic brain tumors
  • Track 5-6Melanoma (skin cancer) and metastatic brain tumors

Meningioma is referred to as slow growing Brain tumors, but their origin is not from the Brain tissue. Meningiomas are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord.

Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.

  • Track 6-1Abnormal Chromosome 22
  • Track 6-2Platelet-Derived Growth Factor (PDGFR)
  • Track 6-3Epidermal Growth Factor Receptors (EGFR)
  • Track 6-4Skull base meningioma
  • Track 6-5Spinal cord tumor in children

Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.

  • Track 7-1Ganglioneuroma
  • Track 7-2Headache
  • Track 7-3Seizures
  • Track 7-4Cognitive problems
  • Track 7-5Hormonal disorders

Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Like other Brain Tumors, Choroid Plexus Tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.

  • Track 8-1Choroid Plexus Papilloma (grade 1)
  • Track 8-2Intermediate Grade (grade 2)
  • Track 8-3Atypical Choroid plexus papilloma (grade 3)

A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.

  • Track 9-1Diffuse intrinsic pontine glioma
  • Track 9-2Focal or low-grade glioma
  • Track 9-3Radiation therapy with radio sensitizers
  • Track 9-4Loss of balance and Trouble walking
  • Track 9-5Vision and Hearing Problems
  • Track 9-6Nausea and Vomiting
  • Track 9-7Unusual Sleepiness

The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as Chemotherapy, Radiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.

Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.

  • Track 10-1Incognition
  • Track 10-2Bipolar disorder
  • Track 10-3Neuropsychiatric Disorders
  • Track 10-4Animal Behavior
  • Track 10-5Sensory Processing
  • Track 10-6Sleep and Communication
  • Track 10-7Learning and Memory
  • Track 10-8Addiction
  • Track 10-9Evolutionary Psychology
  • Track 10-10Psycho-metrics
  • Track 10-11Neuropsychological Impairment
  • Track 10-12Cognitive testing
  • Track 10-13Brain-stimulation treatments

Para Neoplastic Neurological Syndromes (PNS) are defined as the remote effects of cancer on the Nervous System. They are due to the presence of Cancer and exclusion of other known causes of the Neurological symptoms, but this criterion does not separate “true” PNS from Neurological syndromes that are coincidental with a Cancer. 

  • Track 11-1 Metastasis
  • Track 11-2 Encephalomyelitis
  • Track 11-3 Para Neoplastic Neurologic Autoimmunity
  • Track 11-4Neuraxis

The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria. 

  • Track 12-1 Cerebrovascular Disease
  • Track 12-2Response Evaluation
  • Track 12-3Trauma and Tumour
  • Track 12-4Clinical Neuroscience
  • Track 12-5Macdonald Criteria
  • Track 12-6Clinical Trials
  • Track 12-7Clinical Psychology

In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.

  • Track 13-1Central Nervous System Malignancies
  • Track 13-2Primitive Neuroectodermal Tumours
  • Track 13-3platinum-based chemotherapy
  • Track 13-4Whole-brain radiotherapy (WBRT)

The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.

Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer techniques include:

•Antiseizure/Antiepileptic Drugs (AEDs)

•Steroids

•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function

•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.

 

•Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor   growth.

•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.

•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.

  • Track 14-1Computer-Assisted Technology
  • Track 14-2Endoscopy
  • Track 14-3Intraoperative Magnetic Resonance Imaging (MRI)
  • Track 14-4Personalized Vaccines
  • Track 14-5Genomic Sequencing

Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.

  • Track 15-1Positron Emission Tomography (PET)
  • Track 15-2Magneto Encephalography (MEG)
  • Track 15-3Stereotactic Radiosurgery
  • Track 15-4Vincristine

The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.

  • Track 16-1 Neuroinflammation
  • Track 16-2Neuroendocrine Immunology
  • Track 16-3Clinical Neuroimmunology
  • Track 16-4Neuroimmunlogical Disorders
  • Track 16-5Rituximab

Neuroimaging is the Mapping of human Brain using functional Magnetic Resonance Imaging (fMRI). It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis. It includes Multimodality imaging like CT, MRI, PET, to offer most precise information noninvasively, on type of the Tumor and grade; it also guides therapeutic choices and also assesses the effects of therapy

Neuroimaging development, testing, and implementation of advanced MRI and PET Imaging biomarkers for the characterization of Brain Tumor biology and response evaluation in Clinical trials able to detect the biological behaviour of Brain Tumor more accurately.

  • Track 17-1Cranial ultrasound
  • Track 17-2Single-Photon Emission Computed Tomography
  • Track 17-3Brain Mapping
  • Track 17-4Diffuse Optical Imaging
  • Track 17-5Computed Axial Tomography
  • Track 17-6Comparison Of Imaging Types

A Metastatic Cancer is one which has spread from the primary site of origin into different area of the body. That occur in about one-fourth of all cancers that spread through the body.  Treatment for Metastatic Cancer aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, the size and location of the Metastasis, and other factors.

The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.

  • Track 18-1Treatment Algorithm
  • Track 18-2Dexamethasone
  • Track 18-3Famotidine
  • Track 18-4Trimethoprim-Sulfamethoxazole

Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. Some complications seen are

  •  Infection
  •  Fatigue
  •  Bruising
  •  Bleeding
  •  sleep disturbances

Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.

  • Track 19-1Disease Seizures
  • Track 19-2Increased Intracranial Pressure
  • Track 19-3Thromboembolism
  • Track 19-4Neutropenia
  • Track 19-5Thrombocytopenia
  • Track 19-6Neutropenia
  • Track 19-7Anaemia
  • Track 19-8Encephalopathy
  • Track 19-9CNS Infections

To study the effect of drugs on the cellular function in nervous system is called as Neuropharmacology. It is of two types such as; Behavioral neuropharmacology and Molecular neuropharmacology. It explains the drug dependence and addiction effect of brain. The science dealing with the study of the effects of the poisons on the nervous system is called as Neuro toxicology. It happens when nervous system gets affected by the neurotoxins.  It occurs due to the exposure of the chemotherapy, radiation treatment, drug abuse, pesticides etc.

  • Track 20-1Neurotransmitter
  • Track 20-2Neuromodulator
  • Track 20-3Neurotoxin
  • Track 20-4Chemotherapy
  • Track 20-5Clinical Neuropharmacology
  • Track 20-6Molecular Neuropharmacology
  • Track 20-7Neuroanesthesia
  • Track 20-8Behavioral Neuropharmacology
  • Track 20-9Neuroendocrinology and Stroke